· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print) 2020 / N 3 Анализ ведения больных с новой инфекцией COVID-19: опыт первых 5 мес А.А. Визель, Д.И. Абдулганиева, А.Д. Баялиева, А.А. Ванюшин, И.Н. Салахова, А.Р. Вафина, П.Е. Колесников, Е.В. Сушенцова, М.К. Сагьдиева, Е.А. Соболева, И.Ю. Визель References 1. Jin YH, Cai L, Cheng ZS, Deng T, Fan YP, Fang C, Huang D, Huang LQ, Huang Q, Han Y, Hu B, Hu F, Li BH, Li YR, Liang K, Lin LK, Luo LS, Ma J, Ma LL, Peng ZY, Pan YB, Pan ZY, Ren XQ, Sun HM, Wang Y, Wang YY, Weng H, Wei CJ, Wu DF, Xia J, Xiong Y, Xu HB, Yao XM, Yuan YF, Ye TS, Zhang ZC, Zhang YW, Zhang YG, Zhang HM, Zhao Y, Zhao MJ, Zi H, Zeng XT, Wang YY, Wang XH for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research 2020 Feb;7(1):4. 2. Ministry of Healthcare of the Russian Federation. Prevention, diagnosis and treatment of new coronavirus infection (2019-nCoV): temporary guidelines. Version 1 dated 2020 Jan 29. Moscow, 2020. 51 p. (In Russian). 3. Sun H, Jain A, Leone MJ, Alabsi HS, Brenner LN, Ye E, Ge W, Shao YP, Boutros CL, Wang R, Tesh RA, Magdamo C, Collens SI, Ganglberger W, Bassett IV, Meigs JB, Kalpathy-Cramer J, Li MD, Chu JT, Dougan ML, Stratton LW, Rosand J, Fischl B, Das S, Mukerji SS, Robbins GK, Westover MB. CoVA: an Acuity Score for outpatient screening that predicts COVID-19 prognosis. The Journal of Infectious Diseases 2021 Jan;223(1):38-46. 4. Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, Wooster L, Rotter JI, Guo X, Malhotra R. Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. Journal of Medical Virology 2020 Oct;92(10):1875-83. 5. Ahnach M, Zbiri S, Nejjari S, Ousti F, Elkettani C. C-reactive protein as an early predictor of COVID-19 severity. Journal of Medial Biochemistry 2020 Oct;39(4):500-7. 6. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, Fermín-Martínez CA, Naveja JJ, Aguilar-Salinas CA. Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. The Journal of Clinical Endocrinology and Metabolism 2020 Aug;105(8):dgaa346. 7. Wang JM, Liu W, Chen X, McRae MP, McDevitt JT, Fenyö D. Predictive modeling of morbidity and mortality in COVID-19 hospitalized patients and its clinical implications. medRxiv 2020 Dec 5;2020.12.02.20235879. Preprint. 8. Zaytsev AA, Chernov SA, Kryukov EV, Golukhova ES, Rybka MM. Practical experience of managing patients with novel coronavirus infection COVID-19 in hospital (preliminary results and guidelines). Lechashchiy Vrach Journal 2020;6:74-9 (In Russian). 9. Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse T, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell LC, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ; RECOVERY Collaborative Group. Effect of hydroxychloroquine in hospitalized patients with Covid-19. The New England Journal of Medicine 2020 Nov;383(21):2030-40. 10. Chen J, Liu D, Liu L, Liu P, Xu Q, Xia L, Ling Y, Huang D, Song S, Zhang D, Qian Z, Li T, Shen Y, Lu H. A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020 May;49(2):215-9. 11. Choudhary R, Sharma AK. Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance. New Microbes and New Infections 2020 Apr;35:100684. 12. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Sevestre J, Mailhe M, Doudier B, Aubry C, Amrane S, Seng P, Hocquart M, Eldin C, Finance J, Vieira VE, Tissot-Dupont HT, Honoré S, Stein A, Million M, Colson P, La Scola B, Veit V, Jacquier A, Deharo JC, Drancourt M, Fournier PE, Rolain JM, Brouqui P, Raoult D. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Travel Medicine and Infectious Disease 2020 Mar-Apr;34:101663. 13. Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, Weinberg P, Kirkwood J, Muse A, DeHovitz J, Blog DS, Hutton B, Holtgrave DR, Zucker HA. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state. JAMA 2020 Jun;323(24):2493-502. 14. Nojomi M, Yassin Z, Keyvani H, Makiani MJ, Roham M, Laali A, Dehghan N, Navaei M, Ranjbar M. Effect of arbidol (umifenovir) on COVID-19: a randomized controlled trial. BMC Infectious Diseases 2020 Dec;20(1):954. 15. Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt SJ, Kollmann TR, Fish EN. Interferon-α2b treatment for COVID-19. Frontiers in Immunology 2020 May;11:1061. 16. Liu JY, Hua MX, Du CJ, Pu L, Xiang P, Li CS, Xiong HF, Liu XZ, Chen ZH, Xie W, Li A. The dual role of anti-viral therapy in the treatment of Coronavirus disease 2019. European Review for Medical and Pharmacological Sciences 2020 Nov;24(22):11939-44. 17. RECOVERY Collaborative Group. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet 2020 Oct;396(10259):1345-52. 18. Price LC, McCabe C, Garfield B, Wort SJ. Thrombosis and COVID-19 pneumonia: the clot thickens! The European Respiratory Journal 2020 Jun;56(1):2001608. 19. Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis. Thrombosis Research 2020 Dec;196:67-74. 20. Roytman EV, Bulanov AYu, Pechennikov VM. Low-molecular-weight heparin dosing and anti-factor Xa activity in patients with novel coronavirus infection COVID-19. Thrombosis, Hemostasis and Rheology 2020;4:57-67 (In Russian). 21. Rentsch CT, Beckman JA, Tomlinson L, Gellad WF, Alcorn C, Kidwai-Khan F, Skanderson M, Brittain E, King JT, Ho YL, Eden S, Kundu S, Lann MF, Greevy RA, Ho PM, Heidenreich PA, Jacobson DA, Douglas IJ, Tate JP, Evans SJ, Atkins D, Justice AC, Freiberg MS. Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States. medRxiv 2020 Dec 11;2020.12.09.20246579. Preprint. 22. Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, Miller J, Kenney RM, Alangaden G, Ramesh MS; Henry Ford COVID-19 Management Task Force. Early short-course corticosteroids in hospitalized patients with COVID-19. Clinical Infectious Diseases 2020 Nov;71(16):2114-20. 23. Kolilekas L, Loverdos K, Giannakaki S, Vlassi L, Levounets A, Zervas E, Gaga M. Can steroids reverse the severe COVID-19 induced "cytokine storm"? Journal of Medical Virology 2020 Nov;92(11):2866-9. 24. Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JPT, Horby P, Jüni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, Møller MH, Perner A, Petersen MW, Savovic, Tomazini, Veiga, Webb S, Marshall JC; WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 2020;324(13):1-13. 25. Zaytsev AA, Golukhova EZ, Mamalyga ML, Chernov SA, Rybka MM, Kryukov EV, Klyuchnikov IV, Semenov VYu, Orlov IN. Efficacy of methylprednisolone pulse therapy in patients with COVID-19. Clinical Microbiology and Antimicrobial Chemotherapy 2020;22(2):88-91 (In Russian). 26. Vidal-Cortés P, Del Río-Carbajo L, Nieto-Del Olmo J, Prol-Silva E, Tizón-Varela AI, Rodríguez-Vázquez A, Rodríguez-Rodríguez P, Díaz-López MD, Fernández-Ugidos P, Pérez-Veloso MA. COVID-19 and acute respiratory distress syndrome. Impact of corticosteroid treatment and predictors of poor outcome. Revista Española de Quimioterapia 2021 Feb;34(1):33-43. 27. Arshad M, Mahmood SF, Khan M, Hasan R. Covid-19, misinformation, and antimicrobial resistance. BMJ 2020 Nov;371:m4501. 28. Rossotti R, Travi G, Ughi N, Corradin M, Baiguera C, Fumagalli R, Bottiroli M, Mondino M, Merli M, Bellone A, Basile A, Ruggeri R, Colombo F, Moreno M, Pastori S, Perno CF, Tarsia P, Epis OM, Puoti M; Niguarda COVID-19 Working Group. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: a comparative analysis. The Journal of Infection 2020 Oct;81(4):e11-7.    [ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]